STOCK TITAN

Vor Bio to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, announced its participation in several investor conferences in September 2022.

The events include:

  • Morgan Stanley 20th Annual Global Healthcare Conference: September 12, 2022, at 4:50 pm ET in New York, NY
  • H.C. Wainwright 24th Annual Global Investment Conference: September 14, 2022, at 8:30 am ET in New York, NY
  • Baird’s 2022 Global Healthcare Conference: September 14, 2022, at 10:50 am ET in New York, NY
  • Jefferies Cell and Genetic Medicine Summit: September 30, 2022, in New York, NY

A live webcast of the Morgan Stanley chat will be available on vorbio.com.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference
Fireside Chat: Monday, September 12, 2022 at 4:50 pm ET
Location: Sheraton Hotel, New York, NY

H.C. Wainwright 24th Annual Global Investment Conference (Hybrid)
Fireside chat: Wednesday, September 14, 2022 at 8:30 am ET
Location: Lotte New York Palace Hotel, New York, NY

Baird’s 2022 Global Healthcare Conference
Fireside chat: Wednesday, September 14, 2022 at 10:50 am ET
Location: Intercontinental New York Barclay, New York, NY

Jefferies Cell and Genetic Medicine Summit
Fireside chat: Friday, September 30, 2022
Location: Lotte New York Palace Hotel, New York, NY

A live webcast and archived replay of the fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference will be available on the investors section of www.vorbio.com.

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


FAQ

What conferences is Vor Bio participating in September 2022?

Vor Bio is participating in the Morgan Stanley 20th Annual Global Healthcare Conference, H.C. Wainwright 24th Annual Global Investment Conference, Baird's 2022 Global Healthcare Conference, and Jefferies Cell and Genetic Medicine Summit.

When is Vor Bio's fireside chat at the Morgan Stanley conference?

Vor Bio's fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference is scheduled for September 12, 2022, at 4:50 pm ET.

What is the location of the H.C. Wainwright conference for Vor Bio?

The H.C. Wainwright 24th Annual Global Investment Conference for Vor Bio will take place at the Lotte New York Palace Hotel in New York, NY on September 14, 2022.

Is there a webcast for the Morgan Stanley conference?

Yes, Vor Bio will provide a live webcast and archived replay of its fireside chat at the Morgan Stanley conference on its investor section of vorbio.com.

What is Vor Bio's focus in the healthcare industry?

Vor Bio focuses on engineering hematopoietic stem cells to support targeted therapies for blood cancer patients.

Vor Biopharma Inc.

NASDAQ:VOR

VOR Rankings

VOR Latest News

VOR Stock Data

54.58M
67.89M
1.17%
81.25%
2.49%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE